QuickLinks -- Click here to rapidly navigate through this document

EXHIBIT 23.2

CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

    We consent to the reference to our firm under the caption "Experts" and to the use of our report dated October 6, 2000, with respect to the financial statements of ImmGenics Pharmaceuticals Inc., in the Post-Effective Amendment No. 2 to the Registration Statement (Form S-1 No. 333-49858) and related Prospectus of Abgenix, Inc. for the registration of 4,050,000 shares of its common stock.

/s/ Ernst & Young LLP
Chartered Accountants

Vancouver, Canada
October 11, 2001

QuickLinks

CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS